Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a medicated cloth stop prosthetic sweating woes?

NCT ID NCT04924036

Symptom relief Sponsor: University of Utah Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

This study tested whether a medicated cloth (glycopyrronium) could reduce excessive sweating at the amputation site in 13 limb amputees. Participants used either the active cloth or a placebo for four weeks, then switched after a washout period. The goal was to see if less sweating would improve how well the prosthetic fits and feels.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
glycopyrronium cloths (Qbrexza)
What this could lead to
If it works, this could offer a simple topical treatment to reduce sweating at amputation sites, helping prosthetics fit better and improving comfort.
What could go wrong
This is a small, early-phase trial with only 13 participants, so results may not apply widely. The treatment may not work for everyone, and side effects like skin irritation are possible.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Phase 2

Tests whether the treatment actually works, and watches for side effects, in a larger group.

Participants

13 people

The number who actually took part.

Started

Sep 2021

Finished

Dec 2023

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. History of limb amputation with limb-amputation surgery at least 6 months ago 2. Have a prosthetic device 4\. HDSS of 3 or greater (at screening) 5. ASDD-m Item 2 severity score \>= 4 (at screening) 6. PFFQ score \>= 4 (at screening) Exclusion Criteria: 1. Open sores or wounds on residual limb (at screening and baseline) 2. Known sensitivity to glycopyrronium tosylate or other component of Qbrexza 3. Pregnant or lactating. 4. Use of botulinum toxin within 1 year of the baseline visit 5. Use of topical aluminum chloride within 1 month of the baseline visit 6. Any significant concurrent condition that could adversely affect the patient's participation and/or the assessment of the safety and efficacy in the study in the opinion of the investigator

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Amputation are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Hyperhidrosis hyperhidrosis palmaris ET plantaris

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Amputation Hyperhidrosis

Contacts and locations

Locations

  • University of Utah MidValley Dermatology

    Murray, Utah, 84107, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.